All stock lists
AEON Biopharma, Inc. (New York Stock Exchange Arca:AEON)
US · Delayed Price · Currency is USD
0.24+0.00 (+0.42%)
Insider Score
––Not scored
AEON Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AEON Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 20.00 K | 19.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -20.00 K | -19.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 2.97 M | 3.88 M | 3.89 M | 1.93 M | 3.26 M | 3.13 M |
| R&D Expense | 2.94 M | 2.03 M | 1.61 M | 597.00 K | 1.06 M | 825.00 K |
| Operating Expenses | 5.91 M | 5.92 M | 5.51 M | 2.49 M | 4.34 M | 462.00 K |
| Operating Income | -5.93 M | -5.94 M | -5.51 M | -2.49 M | -4.34 M | -462.00 K |
| Pretax Income | -1.16 M | -11.79 M | -37.14 M | -4.54 M | -6.64 M | 9.10 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.16 M | -11.79 M | -37.14 M | -4.54 M | -6.64 M | 9.10 M |
| EPS (Basic) | -0.02 | -0.29 | -3.07 | -0.39 | -0.60 | 2.28 |
| EPS (Diluted) | -0.02 | -0.29 | -3.07 | -0.39 | -0.60 | 2.28 |
| Shares Outstanding | 50.53 M | 40.61 M | 12.11 M | 11.63 M | 11.09 M | 3.98 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.